Bausch Health Companies | VRX - Equity Capital And Reserves



Bausch Health Companies reported $147M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Amgen USD 7.43B 1.22B Jun/2025
ANI Pharmaceuticals USD 436.76M 18.14M Jun/2025
Aurora Cannabis CAD 588.68M 15.76M Jun/2025
Bausch Health Companies USD 147M 1.33B Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
Bristol-Myers Squibb USD 17.49B 100M Jun/2025
Canopy Growth CAD 488.98M 102.49M Jun/2025
Corcept Therapeutics USD 635.79M 47.49M Jun/2025
Danaher USD 52.33B 1.48B Jun/2025
Drreddys Laboratories INR 353.76B 36.03B Jun/2025
Eli Lilly USD 18.27B 2.43B Jun/2025
Gilead Sciences USD 19.67B 596M Jun/2025
Novo Nordisk 168.07B 29.53B Jun/2025
Pacira USD 757.77M 40.77M Jun/2025
Perrigo USD 4.47B 108.3M Jun/2025
Prestige Brands USD 1.86B 20.58M Jun/2025
Supernus Pharmaceuticals USD 1.06B 33.2M Jun/2025
Vertex Pharmaceuticals USD 17.18B 679.1M Jun/2025
Zoetis USD 4.98B 322M Jun/2025